Journal of Clinical Oncology, Vol 11, 1216-1222, Copyright © 1993 by American Society of Clinical Oncology

ARTICLES

Adjuvant treatment of stage I lung cancer with high-dose vitamin A

U Pastorino, M Infante, M Maioli, G Chiesa, M Buyse, P Firket, N Rosmentz, M Clerici, E Soresi and M Valente
Istituto Nazionale Tumori, Ospedale Niguarda, Milan, Italy.

PURPOSE: Vitamin A and retinoids are strong inhibitors of epithelial cancer promotion and progression in experimental carcinogenesis. This study examined whether they may prevent the occurrence of upper aerodigestive cancer in subjects heavily exposed to tobacco smoking, such as patients already cured of an early-stage lung cancer. PATIENTS AND METHODS: The adjuvant effect of high-dose vitamin A was tested on 307 patients with stage I non-small-cell lung cancer. After curative surgery, patients were randomly assigned to either a group prescribed retinol palmitate administration (orally 300,000 IU daily for 12 months) or a control group prescribed no treatment. RESULTS: After a median follow-up of 46 months, the number of patients with either recurrence or new primary tumors was 56 (37%) in the treated arm and 75 (48%) in the control arm. Eighteen patients in the treated group developed a second primary tumor, and 29 patients in the control group developed 33 second primary tumors. A statistically significant difference in favor of treatment was observed concerning time to new primary tumors in the field of prevention (P = .045, log-rank test). The treatment difference in terms of disease-free interval was close to statistical significance (P = .054, log-rank test) and just significant when adjusted for primary tumor classification (P = .038, Cox regression model). CONCLUSION: Daily oral administration of high-dose vitamin A is effective in reducing the number of new primary tumors related to tobacco consumption and may improve the disease-free interval in patients curatively resected for stage I lung cancer. The impact of such a treatment on survival needs to be further explored.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				Y. Wang, Z. Zhang, J. R. Garbow, D. J. Rowland, R. A. Lubet, D. Sit, F. Law, and M. You Chemoprevention of Lung Squamous Cell Carcinoma in Mice by a Mixture of Chinese Herbs Cancer Prevention Research, July 1, 2009; 2(7): 634 - 640. [Abstract] [Full Text] [PDF]

				Y. NAKAYAMA, Y. INOUE, N. MINAGAWA, K. ONITSUKA, J. NAGATA, K. SHIBAO, K. HIRATA, T. SAKO, N. NAGATA, and K. YAMAGUCHI Chemopreventive Effect of 4-[3,5-Bis(trimethylsilyl) benzamido] Benzoic Acid (TAC-101) on MNU-induced Colon Carcinogenesis in a Rat Model Anticancer Res, June 1, 2009; 29(6): 2059 - 2065. [Abstract] [Full Text] [PDF]

				S. J. Freemantle, Y. Guo, and E. Dmitrovsky Retinoid Chemoprevention Trials: Cyclin D1 in the Crosshairs Cancer Prevention Research, January 1, 2009; 2(1): 3 - 6. [Full Text] [PDF]

				A. Bardia, I. M. Tleyjeh, J. R. Cerhan, A. K. Sood, P. J. Limburg, P. J. Erwin, and V. M. Montori Efficacy of Antioxidant Supplementation in Reducing Primary Cancer Incidence and Mortality: Systematic Review and Meta-analysis Mayo Clin. Proc., January 1, 2008; 83(1): 23 - 34. [Abstract] [Full Text] [PDF]

				K. Chen, R. Sawhney, M. Khan, M. S. Benninger, Z. Hou, S. Sethi, J. K. Stephen, and M. J. Worsham Methylation of Multiple Genes as Diagnostic and Therapeutic Markers in Primary Head and Neck Squamous Cell Carcinoma Arch Otolaryngol Head Neck Surg, November 1, 2007; 133(11): 1131 - 1138. [Abstract] [Full Text] [PDF]

				J. Rubins, M. Unger, and G. L. Colice Follow-up and Surveillance of the Lung Cancer Patient Following Curative Intent Therapy: ACCP Evidence-Based Clinical Practice Guideline (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 355S - 367S. [Abstract] [Full Text] [PDF]

				O. Oppenheimer, N.-K. Cheung, and W. L. Gerald The RET oncogene is a critical component of transcriptional programs associated with retinoic acid-induced differentiation in neuroblastoma Mol. Cancer Ther., April 1, 2007; 6(4): 1300 - 1309. [Abstract] [Full Text] [PDF]

				A. A. Davies, G. Davey Smith, R. Harbord, G. E. Bekkering, J. A. C. Sterne, R. Beynon, and S. Thomas Nutritional interventions and outcome in patients with cancer or preinvasive lesions: systematic review. J Natl Cancer Inst, July 19, 2006; 98(14): 961 - 973. [Abstract] [Full Text] [PDF]

				S. J. Freemantle, K. H. Dragnev, and E. Dmitrovsky The retinoic Acid paradox in cancer chemoprevention. J Natl Cancer Inst, April 5, 2006; 98(7): 426 - 427. [Full Text] [PDF]

				F. R. Khuri, J. J. Lee, S. M. Lippman, E. S. Kim, J. S. Cooper, S. E. Benner, R. Winn, T. F. Pajak, B. Williams, G. Shenouda, et al. Randomized Phase III Trial of Low-dose Isotretinoin for Prevention of Second Primary Tumors in Stage I and II Head and Neck Cancer Patients. J Natl Cancer Inst, April 5, 2006; 98(7): 441 - 450. [Abstract] [Full Text] [PDF]

				H. Sugimura and P. Yang Long-term Survivorship in Lung Cancer: A Review. Chest, April 1, 2006; 129(4): 1088 - 1097. [Abstract] [Full Text] [PDF]

				W. J. Petty, N. Li, A. Biddle, R. Bounds, C. Nitkin, Y. Ma, K. H. Dragnev, S. J. Freemantle, and E. Dmitrovsky A Novel Retinoic Acid Receptor {beta} Isoform and Retinoid Resistance in Lung Carcinogenesis J Natl Cancer Inst, November 16, 2005; 97(22): 1645 - 1651. [Abstract] [Full Text] [PDF]

				F. R. Khuri and R. Lotan Retinoids in Lung Cancer: Friend, Foe, or Fellow Traveler? J. Clin. Oncol., September 1, 2004; 22(17): 3435 - 3437. [Full Text] [PDF]

				J. S. Kim, H. Lee, H. Kim, Y. M. Shim, J. Han, J. Park, and D.-H. Kim Promoter Methylation of Retinoic Acid Receptor Beta 2 and the Development of Second Primary Lung Cancers in Non-Small-Cell Lung Cancer J. Clin. Oncol., September 1, 2004; 22(17): 3443 - 3450. [Abstract] [Full Text] [PDF]

				C Jeronimo, R Henrique, J Oliveira, F Lobo, I Pais, M R Teixeira, and C Lopes Aberrant cellular retinol binding protein 1 (CRBP1) gene expression and promoter methylation in prostate cancer J. Clin. Pathol., August 1, 2004; 57(8): 872 - 876. [Abstract] [Full Text] [PDF]

				F. R. Khuri and V. Cohen Molecularly Targeted Approaches to the Chemoprevention of Lung Cancer Clin. Cancer Res., June 15, 2004; 10(12): 4249S - 4253S. [Abstract] [Full Text] [PDF]

				A. S. Tsao, E. S. Kim, and W. K. Hong Chemoprevention of Cancer CA Cancer J Clin, May 1, 2004; 54(3): 150 - 180. [Abstract] [Full Text] [PDF]

				K. H. Dragnev, I. Pitha-Rowe, Y. Ma, W. J. Petty, D. Sekula, B. Murphy, M. Rendi, N. Suh, N. B. Desai, M. B. Sporn, et al. Specific Chemopreventive Agents Trigger Proteasomal Degradation of G1 Cyclins: Implications for Combination Therapy Clin. Cancer Res., April 1, 2004; 10(7): 2570 - 2577. [Abstract] [Full Text] [PDF]

				R. C. Winterhalder, F. R. Hirsch, G. K. Kotantoulas, W. A. Franklin, and P. A. Bunn Jr Chemoprevention of lung cancer--from biology to clinical reality Ann. Onc., February 1, 2004; 15(2): 185 - 196. [Abstract] [Full Text] [PDF]

				A. M Myhre, M. H Carlsen, S. K Bohn, H. L Wold, P. Laake, and R. Blomhoff Water-miscible, emulsified, and solid forms of retinol supplements are more toxic than oil-based preparations Am. J. Clinical Nutrition, December 1, 2003; 78(6): 1152 - 1159. [Abstract] [Full Text] [PDF]

				Y. Wang, M. Z. Fang, J. Liao, G.-Y. Yang, Y. Nie, Y. Song, C. So, X. Xu, L.-D. Wang, and C. S. Yang Hypermethylation-Associated Inactivation of Retinoic Acid Receptor {beta} in Human Esophageal Squamous Cell Carcinoma Clin. Cancer Res., November 1, 2003; 9(14): 5257 - 5263. [Abstract] [Full Text] [PDF]

				D. Rice, H.-W. Kim, A. Sabichi, S. Lippman, J. J. Lee, B. Williams, A. Vaporciyan, W. R. Smythe, S. Swisher, G. Walsh, et al. The risk of second primary tumors after resection of Stage I nonsmall cell lung cancer Ann. Thorac. Surg., October 1, 2003; 76(4): 1001 - 1008. [Abstract] [Full Text] [PDF]

				T. Kakizoe Chemoprevention of Cancer - Focusing on Clinical Trials Jpn. J. Clin. Oncol., September 1, 2003; 33(9): 421 - 442. [Abstract] [Full Text] [PDF]

				K. H. Dragnev, D. Stover, and E. Dmitrovsky Lung Cancer Prevention: The Guidelines Chest, January 1, 2003; 123(1_suppl): 60S - 71S. [Abstract] [Full Text] [PDF]

				W. A. Weiger, M. Smith, H. Boon, M. A. Richardson, T. J. Kaptchuk, and D. M. Eisenberg Advising Patients Who Seek Complementary and Alternative Medical Therapies for Cancer Ann Intern Med, December 3, 2002; 137(11): 889 - 903. [Abstract] [Full Text] [PDF]

				M. Esteller, M. Guo, V. Moreno, M. A. Peinado, G. Capella, O. Galm, S. B. Baylin, and J. G. Herman Hypermethylation-associated Inactivation of the Cellular Retinol-Binding-Protein 1 Gene in Human Cancer Cancer Res., October 15, 2002; 62(20): 5902 - 5905. [Abstract] [Full Text] [PDF]

				E. C. Tibaduiza, J. C. Fleet, R. M. Russell, and N. I. Krinsky Excentric Cleavage Products of {beta}-Carotene Inhibit Estrogen Receptor Positive and Negative Breast Tumor Cell Growth In Vitro and Inhibit Activator Protein-1-Mediated Transcriptional Activation J. Nutr., June 1, 2002; 132(6): 1368 - 1375. [Abstract] [Full Text] [PDF]

				S. Bruno, C. Tenca, D. Saverino, E. Ciccone, and C. E. Grossi Apoptosis of squamous cells at different stages of carcinogenesis following 4-HPR treatment Carcinogenesis, March 1, 2002; 23(3): 447 - 456. [Abstract] [Full Text] [PDF]

				J. A. O'Shaughnessy, G. J. Kelloff, G. B. Gordon, A. J. Dannenberg, W. K. Hong, C. J. Fabian, C. C. Sigman, M. M. Bertagnolli, S. P. Stratton, S. Lam, et al. Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development : Recommendations of the American Association for Cancer Research Task Force on the Treatment and Prevention of Intraepithelial Neoplasia Clin. Cancer Res., February 1, 2002; 8(2): 314 - 346. [Abstract] [Full Text] [PDF]

				S. M. Lippman and M. R. Spitz Lung Cancer Chemoprevention: An Integrated Approach J. Clin. Oncol., September 15, 2001; 19(90001): 74s - 82. [Abstract] [Full Text] [PDF]

				J.-C. Soria, C. Moon, L. Wang, W. N. Hittelman, S. J. Jang, S.-Y. Sun, J. J. Lee, D. Liu, J. M. Kurie, R. C. Morice, et al. Effects of N-(4-Hydroxyphenyl)retinamide on hTERT Expression in the Bronchial Epithelium of Cigarette Smokers J Natl Cancer Inst, August 15, 2001; 93(16): 1257 - 1263. [Abstract] [Full Text] [PDF]

				R A Sharma, A J Gescher, K J O'Byrne, and W P Steward Familiar drugs may prevent cancer Postgrad. Med. J., August 1, 2001; 77(910): 492 - 497. [Abstract] [Full Text] [PDF]

				J. Prudencio, N. Akutsu, N. Benlimame, T. Wang, Y. Bastien, R. Lin, M. J. Black, M. A. Alaoui-Jamali, and J. H. White Action of Low Calcemic 1{{alpha}},25-Dihydroxyvitamin D3 Analogue EB1089 in Head and Neck Squamous Cell Carcinoma J Natl Cancer Inst, May 16, 2001; 93(10): 745 - 753. [Abstract] [Full Text] [PDF]

				J. Brown, T. Byers, K. Thompson, B. Eldridge, C. Doyle, A. M. Williams, and American Cancer Society Workgroup on Nutrition and Nutrition During and After Cancer Treatment: A Guide for Informed Choices by Cancer Survivors CA Cancer J Clin, May 1, 2001; 51(3): 153 - 181. [Abstract] [Full Text] [PDF]

				S. M. Lippman, J. J. Lee, D. D. Karp, E. E. Vokes, S. E. Benner, G. E. Goodman, F. R. Khuri, R. Marks, R. J. Winn, W. Fry, et al. Randomized Phase III Intergroup Trial of Isotretinoin to Prevent Second Primary Tumors in Stage I Non-Small-Cell Lung Cancer J Natl Cancer Inst, April 18, 2001; 93(8): 605 - 618. [Abstract] [Full Text] [PDF]

				F. R. Khuri, J. S. Lee, S. M. Lippman, J. J. Lee, S. Kalapurakal, R. Yu, J. Y. Ro, R. C. Morice, W. K. Hong, and W. N. Hittelman Modulation of Proliferating Cell Nuclear Antigen in the Bronchial Epithelium of Smokers Cancer Epidemiol. Biomarkers Prev., April 1, 2001; 10(4): 311 - 318. [Abstract] [Full Text]

				B. Jeremic, Y. Shibamoto, L. Acimovic, N. Nikolic, A. Dagovic, J. Aleksandrovic, and G. Radosavljevic-Asic Second Cancers Occurring in Patients With Early Stage Non-Small-Cell Lung Cancer Treated With Chest Radiation Therapy Alone J. Clin. Oncol., February 15, 2001; 19(4): 1056 - 1063. [Abstract] [Full Text] [PDF]

				K. H. Dragnev, J. R. Rigas, and E. Dmitrovsky The Retinoids and Cancer Prevention Mechanisms Oncologist, October 1, 2000; 5(5): 361 - 368. [Abstract] [Full Text]

				K. Wu, H.-T. Kim, J. L. Rodriquez, D. Munoz-Medellin, S. K. Mohsin, S. G. Hilsenbeck, W. W. Lamph, M. M. Gottardis, M. A. Shirley, J. G. Kuhn, et al. 9-cis-Retinoic Acid Suppresses Mammary Tumorigenesis in C3(1)-Simian Virus 40 T Antigen-transgenic Mice Clin. Cancer Res., September 1, 2000; 6(9): 3696 - 3704. [Abstract] [Full Text]

				J. M. Kurie, J. S. Lee, F. R. Khuri, L. Mao, R. C. Morice, J. J. Lee, G. L. Walsh, A. Broxson, S. M. Lippman, J. Y. Ro, et al. N-(4-Hydroxyphenyl)Retinamide in the Chemoprevention of Squamous Metaplasia and Dysplasia of the Bronchial Epithelium Clin. Cancer Res., August 1, 2000; 6(8): 2973 - 2979. [Abstract] [Full Text]

				N. van Zandwijk, O. Dalesio, U. Pastorino, N. de Vries, and H. van Tinteren EUROSCAN, a Randomized Trial of Vitamin A and N-Acetylcysteine in Patients With Head and Neck Cancer or Lung Cancer J Natl Cancer Inst, June 21, 2000; 92(12): 977 - 986. [Abstract] [Full Text] [PDF]

				M. Widschwendter, J. Berger, M. Hermann, H. M. Muller, A. Amberger, M. Zeschnigk, A. Widschwendter, B. Abendstein, A. G. Zeimet, G. Daxenbichler, et al. Methylation and Silencing of the Retinoic Acid Receptor-{beta}2 Gene in Breast Cancer J Natl Cancer Inst, May 17, 2000; 92(10): 826 - 832. [Abstract] [Full Text] [PDF]

				J. Deslauriers and J. Gregoire Surgical Therapy of Early Non-Small Cell Lung Cancer Chest, April 1, 2000; 117(4_suppl_1): 104S - 109S. [Abstract] [Full Text] [PDF]

				P. Pierard, P. Vermylen, T. Bosschaerts, C. Roufosse, T. Berghmans, J.-P. Sculier, and V. Ninane Synchronous Roentgenographically Occult Lung Carcinoma in Patients With Resectable Primary Lung Cancer Chest, March 1, 2000; 117(3): 779 - 785. [Abstract] [Full Text] [PDF]

				S. M. Lippman and R. Lotan Advances in the Development of Retinoids as Chemopreventive Agents J. Nutr., February 1, 2000; 130(2): 479 - 479. [Abstract] [Full Text]

				D. M. Shin, L. Mao, V. M. Papadimitrakopoulou, G. Clayman, A. El-Naggar, H. J. C. Shin, J. J. Lee, J. S. Lee, A. Gillenwater, J. Myers, et al. Biochemopreventive Therapy for Patients With Premalignant Lesions of the Head and Neck and p53 Gene Expression J Natl Cancer Inst, January 5, 2000; 92(1): 69 - 73. [Full Text] [PDF]

				A. F. Soriano, B. Helfrich, D. C. Chan, L. E. Heasley, P. A. Bunn Jr., and T.-C. Chou Synergistic Effects of New Chemopreventive Agents and Conventional Cytotoxic Agents against Human Lung Cancer Cell Lines Cancer Res., December 1, 1999; 59(24): 6178 - 6184. [Abstract] [Full Text] [PDF]

				J. Ayoub, R. Jean-Francois, Y. Cormier, D. Meyer, Y. Ying, P. Major, C. Desjardins, and W.E.C. Bradley Placebo-Controlled Trial of 13-cis-Retinoic Acid Activity on Retinoic Acid Receptor-Beta Expression in a Population at High Risk: Implications for Chemoprevention of Lung Cancer J. Clin. Oncol., November 1, 1999; 17(11): 3546 - 3552. [Abstract] [Full Text] [PDF]

				Prevention of Cancer in the Next Millennium: Report of the Chemoprevention Working Group to the American Association for Cancer Research Cancer Res., October 1, 1999; 59(19): 4743 - 4758. [Full Text] [PDF]

				E. Picard, C. Seguin, N. Monhoven, C. Rochette-Egly, J. Siat, J. Borrelly, Y. Martinet, N. Martinet, and J. M. Vignaud Expression of Retinoid Receptor Genes and Proteins in Non-Small-Cell Lung Cancer J Natl Cancer Inst, June 16, 1999; 91(12): 1059 - 1066. [Abstract] [Full Text] [PDF]

				B. Cartmel, T. E Moon, and N. Levine Effects of long-term intake of retinol on selected clinical and laboratory indexes Am. J. Clinical Nutrition, May 1, 1999; 69(5): 937 - 943. [Abstract] [Full Text] [PDF]

				L. Sibulesky, K. Hayes, A. Pronczuk, C. Weigel-DiFranco, B. Rosner, and E. L Berson Safety of <7500 RE (<25000 IU) vitamin A daily in adults with retinitis pigmentosa Am. J. Clinical Nutrition, April 1, 1999; 69(4): 656 - 663. [Abstract] [Full Text] [PDF]

				F. L. Meyskens, Jr., S. M. Lippman, J. J. Lee, and A. L. Sabichi Re: Cancer Chemoprevention: Progress and Promise • RESPONSE J Natl Cancer Inst, March 17, 1999; 91(6): 563 - 565. [Full Text] [PDF]

				J. O. Boyle, J. Langenfeld, F. Lonardo, D. Sekula, P. Reczek, V. Rusch, M. I. Dawson, and E. Dmitrovsky Cyclin D1 Proteolysis: a Retinoid Chemoprevention Signal in Normal, Immortalized, and Transformed Human Bronchial Epithelial Cells J Natl Cancer Inst, February 17, 1999; 91(4): 373 - 379. [Abstract] [Full Text] [PDF]

				S.-Y. Sun, J. M. Kurie, P. Yue, M. I. Dawson, B. Shroot, R. A. S. Chandraratna, W. K. Hong, and R. Lotan Differential Responses of Normal, Premalignant, and Malignant Human Bronchial Epithelial Cells to Receptor-selective Retinoids Clin. Cancer Res., February 1, 1999; 5(2): 431 - 437. [Abstract] [Full Text] [PDF]

				H. Vainio and M. Rautalahti An International Evaluation of the Cancer Preventive Potential of Vitamin A Cancer Epidemiol. Biomarkers Prev., January 1, 1999; 8(1): 107 - 109. [Abstract] [Full Text] [PDF]

				V. L. Seewaldt, E. C. Dietze, B. S. Johnson, S. J. Collins, and M. B. Parker Retinoic Acid-mediated G1-S-Phase Arrest of Normal Human Mammary Epithelial Cells Is Independent of the Level of p53 Protein Expression Cell Growth Differ., January 1, 1999; 10(1): 49 - 59. [Abstract] [Full Text]

				S. S. Leong, C. M. Rocha Lima, C. A. Sherman, and M. R. Green The 1997 International Staging System for Non-Small Cell Lung Cancer: Have All the Issues Been Addressed? Chest, January 1, 1999; 115(1): 242 - 248. [Abstract] [Full Text] [PDF]

				W. K. Hong and M. B. Sporn Recent Advances in Chemoprevention of Cancer Science, November 7, 1997; 278(5340): 1073 - 1077. [Abstract] [Full Text]

				J. Langenfeld, H. Kiyokawa, D. Sekula, J. Boyle, and E. Dmitrovsky Posttranslational regulation of cyclin D1 by retinoic acid: A chemoprevention mechanism PNAS, October 28, 1997; 94(22): 12070 - 12074. [Abstract] [Full Text] [PDF]

				B.-j. M. van der Leede, C. E. van den Brink, W. W. M. Pijnappel, E. Sonneveld, P. T. van der Saag, and B. van der Burg Autoinduction of Retinoic Acid Metabolism to Polar Derivatives with Decreased Biological Activity in Retinoic Acid-sensitive, but Not in Retinoic Acid-resistant Human Breast Cancer Cells J. Biol. Chem., July 18, 1997; 272(29): 17921 - 17928. [Abstract] [Full Text] [PDF]

				J. Olak and A. Ng Diagnosis and Treatment of Early-Stage Non-Small Cell Lung Cancer Oncologist, August 1, 1996; 1(4): 201 - 209. [Abstract] [Full Text] [PDF]

				R. Lotan, X.-C. Xu, S. M. Lippman, J. Y. Ro, J. S. Lee, J. J. Lee, and W. K. Hong Suppression of Retinoic Acid Receptor-{beta} in Premalignant Oral Lesions and Its Up-Regulation by Isotretinoin N. Engl. J. Med., May 25, 1995; 332(21): 1405 - 1411. [Abstract] [Full Text] [PDF]

				N. Martini, M. S. Bains, M. E. Burt, M. F. Zakowski, P. McCormack, V. W. Rusch, and R. J. Ginsberg Incidence of local recurrence and second primary tumors in resected stage I lung cancer J. Thorac. Cardiovasc. Surg., January 1, 1995; 109(1): 120 - 129. [Abstract] [Full Text]